ADMA vs NDSN · P/E 22, rev $238.9M vs P/E 31, rev $817.7M
ADMA Biologics Inc (ADMA) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
ADMA currently screens at market cap $4.39B and trailing P/E 21.9. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the ADMA and NDSN stock pages for the full models.
Not investment advice.